These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1891 related items for PubMed ID: 26269538

  • 1. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 2. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ, CETRO trial study group.
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [Abstract] [Full Text] [Related]

  • 3. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV, Roest-Schalken ME, Kleefstra N, Roeters van Lennep J, van den Berg M, Fauser BC, Bilo HJ, Sijbrands EJ, Laven JS.
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [Abstract] [Full Text] [Related]

  • 4. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
    de Wilde MA, Veltman-Verhulst SM, Goverde AJ, Lambalk CB, Laven JS, Franx A, Koster MP, Eijkemans MJ, Fauser BC.
    Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
    [Abstract] [Full Text] [Related]

  • 5. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA, Goverde AJ, Veltman-Verhulst SM, Eijkemans MJ, Franx A, Fauser BC, Koster MP.
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [Abstract] [Full Text] [Related]

  • 6. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
    Veltman-Verhulst SM, Goverde AJ, van Haeften TW, Fauser BC.
    Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
    [Abstract] [Full Text] [Related]

  • 7. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O'Reilly MW, Arlt W, Moore K, Behan LA, Sherlock M, Gibney J.
    Hum Reprod; 2018 Sep 01; 33(9):1727-1734. PubMed ID: 30020477
    [Abstract] [Full Text] [Related]

  • 8. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.
    Hum Reprod; 2013 Apr 01; 28(4):1084-91. PubMed ID: 23427231
    [Abstract] [Full Text] [Related]

  • 9. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D, Altinok M, Mumm H, Buch K, Ravn P, Andersen M.
    Hum Reprod; 2014 Aug 01; 29(8):1773-9. PubMed ID: 24903198
    [Abstract] [Full Text] [Related]

  • 10. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.
    Hum Reprod; 2014 Mar 01; 29(3):480-9. PubMed ID: 24457604
    [Abstract] [Full Text] [Related]

  • 11. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep 01; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 12. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
    Hart RJ, Doherty DA, Mori TA, Adams LA, Huang RC, Minaee N, Handelsman DJ, McLachlan R, Norman RJ, Dickinson JE, Olynyk JK, Beilin LJ.
    Hum Reprod; 2019 Mar 01; 34(3):389-402. PubMed ID: 30576537
    [Abstract] [Full Text] [Related]

  • 13. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
    Chen MJ, Han DS, Yang JH, Yang YS, Ho HN, Yang WS.
    Hum Reprod; 2012 Aug 01; 27(8):2476-83. PubMed ID: 22693174
    [Abstract] [Full Text] [Related]

  • 14. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
    Handelsman DJ, Teede HJ, Desai R, Norman RJ, Moran LJ.
    Hum Reprod; 2017 Feb 01; 32(2):418-422. PubMed ID: 27999117
    [Abstract] [Full Text] [Related]

  • 15. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E, Balen AH, Barth JH.
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb 01; 166(2):173-7. PubMed ID: 23102586
    [Abstract] [Full Text] [Related]

  • 16. Sexual dysfunction in women with PCOS: a case control study.
    Pastoor H, Both S, Laan ETM, Laven JSE.
    Hum Reprod; 2023 Nov 02; 38(11):2230-2238. PubMed ID: 37776157
    [Abstract] [Full Text] [Related]

  • 17. ESHRE guideline: ovarian stimulation for IVF/ICSI†.
    Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F.
    Hum Reprod Open; 2020 Nov 02; 2020(2):hoaa009. PubMed ID: 32395637
    [Abstract] [Full Text] [Related]

  • 18. 24-hour movement behaviours and cardiometabolic markers in women with polycystic ovary syndrome (PCOS): a compositional data analysis.
    Pesonen E, Farrahi V, Brakenridge CJ, Ollila MM, Morin-Papunen LC, Nurkkala M, Jämsä T, Korpelainen R, Moran LJ, Piltonen TT, Niemelä M.
    Hum Reprod; 2024 Dec 01; 39(12):2830-2847. PubMed ID: 39366675
    [Abstract] [Full Text] [Related]

  • 19. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar 01; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 20. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):2447-2469. PubMed ID: 37580314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.